NPI: 1619920949 · PERU, IN 46970 · Ambulance · NPI assigned 05/18/2006
Authorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more
| Authorized Official | LALOR, PAULA (DIRECTOR/DELEGATED OFFICIAL) |
| NPI Enumeration Date | 05/18/2006 |
Other providers sharing the same authorized official: LALOR, PAULA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 15,516 | $286K |
| 2019 | 20,787 | $748K |
| 2020 | 24,735 | $898K |
| 2021 | 30,737 | $1.44M |
| 2022 | 39,436 | $2.06M |
| 2023 | 40,437 | $2.13M |
| 2024 | 22,681 | $1.31M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 16,571 | 13,196 | $2.68M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 12,063 | 8,870 | $1.84M |
| 71045 | Radiologic examination, chest; single view | 6,127 | 4,530 | $679K |
| A0427 | Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) | 6,701 | 5,057 | $580K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4,498 | 3,147 | $529K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 6,089 | 4,005 | $331K |
| A0425 | Ground mileage, per statute mile | 11,597 | 7,652 | $321K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 3,848 | 2,906 | $216K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1,502 | 1,223 | $192K |
| A0429 | Ambulance service, basic life support, emergency transport (bls-emergency) | 1,404 | 1,012 | $139K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 5,426 | 4,127 | $134K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 17,154 | 11,751 | $91K |
| 80053 | Comprehensive metabolic panel | 11,472 | 8,041 | $82K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 4,681 | 2,586 | $77K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 420 | 336 | $73K |
| 36415 | Collection of venous blood by venipuncture | 26,139 | 17,611 | $70K |
| 70450 | Computed tomography, head or brain; without contrast material | 774 | 581 | $67K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1,857 | 1,586 | $54K |
| A0426 | Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) | 668 | 496 | $54K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1,832 | 1,561 | $53K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 1,769 | 1,522 | $51K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 149 | 105 | $48K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 679 | 468 | $41K |
| 84484 | 5,479 | 3,225 | $40K | |
| 80050 | General health panel | 356 | 303 | $35K |
| 96361 | Intravenous infusion, hydration; each additional hour | 2,096 | 1,391 | $35K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 882 | 646 | $34K |
| A0428 | Ambulance service, basic life support, non-emergency transport, (bls) | 511 | 373 | $30K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2,124 | 1,538 | $27K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 599 | 418 | $22K |
| 71046 | Radiologic examination, chest; 2 views | 148 | 112 | $20K |
| 80048 | Basic metabolic panel (calcium, ionized) | 3,481 | 2,253 | $16K |
| 81001 | 4,957 | 3,624 | $15K | |
| 85610 | 4,196 | 2,881 | $14K | |
| 83605 | 1,715 | 1,072 | $13K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 1,364 | 937 | $13K |
| 83690 | 2,906 | 1,973 | $13K | |
| 84443 | Thyroid stimulating hormone (TSH) | 1,077 | 826 | $10K |
| 83880 | 606 | 403 | $10K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 73 | 55 | $10K |
| 94760 | 269 | 80 | $9K | |
| 80061 | Lipid panel | 1,177 | 943 | $9K |
| 87430 | 685 | 539 | $8K | |
| J7030 | Infusion, normal saline solution , 1000 cc | 2,125 | 1,647 | $6K |
| 85730 | 1,377 | 935 | $6K | |
| 83735 | 1,190 | 792 | $6K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 422 | 351 | $6K |
| 86140 | 1,187 | 796 | $5K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 75 | 51 | $5K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 371 | 289 | $5K |
| 99218 | 18 | 12 | $4K | |
| 85652 | 1,507 | 1,014 | $3K | |
| 87400 | 718 | 284 | $3K | |
| 82077 | 245 | 183 | $3K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 233 | 172 | $3K |
| 81025 | 393 | 305 | $3K | |
| 82607 | 287 | 221 | $3K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 475 | 357 | $2K |
| 82746 | 251 | 192 | $2K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 52 | 51 | $2K |
| 85379 | 302 | 195 | $2K | |
| 86141 | 207 | 148 | $1K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 388 | 303 | $1K |
| G0378 | Hospital observation service, per hour | 16 | 12 | $1K |
| 85027 | 246 | 145 | $1K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 1,041 | 737 | $996.65 |
| 80076 | 461 | 302 | $982.45 | |
| 87807 | 85 | 69 | $969.40 | |
| 81003 | 533 | 393 | $919.47 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 43 | 31 | $880.58 |
| 84702 | 75 | 53 | $758.96 | |
| 73630 | 21 | 12 | $592.20 | |
| 86850 | 103 | 84 | $451.98 | |
| 87040 | 92 | 42 | $419.45 | |
| 84100 | 142 | 110 | $372.82 | |
| J2704 | Injection, propofol, 10 mg | 46 | 36 | $347.70 |
| 82150 | 106 | 71 | $318.82 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 205 | 147 | $229.13 |
| 86901 | 104 | 85 | $198.85 | |
| 86900 | 104 | 85 | $195.86 | |
| 84481 | 13 | 12 | $193.96 | |
| 86803 | 15 | 13 | $170.51 | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 12 | 12 | $158.55 |
| 87088 | 112 | 79 | $156.12 | |
| 82550 | 32 | 28 | $116.22 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 503 | 358 | $114.74 |
| 84439 | 13 | 12 | $93.86 | |
| 82248 | 47 | 36 | $92.92 | |
| 82043 | 19 | 17 | $86.70 | |
| 86701 | 14 | 12 | $66.99 | |
| 84703 | 12 | 12 | $63.47 | |
| 82570 | 15 | 13 | $56.98 | |
| 85651 | 61 | 42 | $48.29 | |
| 86592 | 13 | 12 | $38.43 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 30 | 26 | $34.25 |
| J1170 | Injection, hydromorphone, up to 4 mg | 26 | 24 | $10.13 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 12 | 12 | $0.00 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 13 | 12 | $0.00 |